Long-term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low-dose IMRT salvage.
about
Treatment of Retinoblastoma: The Role of External Beam RadiotherapyRisk definition and management strategies in retinoblastoma: current perspectivesIntra-Arterial Chemotherapy (Ophthalmic Artery Chemosurgery) for Group D RetinoblastomaAn international survey of classification and treatment choices for group D retinoblastoma.Progress in Small Molecule Therapeutics for the Treatment of Retinoblastoma.Low-Dose Chemoreduction for Infants Diagnosed with Retinoblastoma before 6 Months of Age.Classification of Vitreous Seeds in Retinoblastoma: Correlations with Patient, Tumor, and Treatment CharacteristicsFactors predictive of long-term visual outcomes of Group D eyes treated with chemoreduction and low-dose IMRT salvage: the Children's Hospital Los Angeles experience.Management of retinoblastoma in children: current status.MiR-613 suppresses retinoblastoma cell proliferation, invasion, and tumor formation by targeting E2F5.Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation.First-line intra-arterial versus intravenous chemotherapy in unilateral sporadic group D retinoblastoma: evidence of better visual outcomes, ocular survival and shorter time to success with intra-arterial delivery from retrospective review of 20 yeaLong-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era.Classification and management of seeds in retinoblastoma. Ellsworth Lecture Ghent August 24th 2013.Patterns of subretinal fluid resolution in Group D eyes treated with chemoreduction: Experience from the Children's Hospital Los Angeles/University of Southern California.Potential of Aqueous Humor as a Surrogate Tumor Biopsy for Retinoblastoma.Loss of fundus view as an indication for secondary enucleation in retinoblastoma.Pharmacokinetics, Tissue Localization, Toxicity, and Treatment Efficacy in the First Small Animal (Rabbit) Model of Intra-Arterial Chemotherapy for Retinoblastoma.Optic Nerve Obscuration in Retinoblastoma: A Risk Factor for Optic Nerve Invasion?Primary intravenous chemotherapy for group D retinoblastoma: a 13-year retrospective analysis.Ten-year experience with ophthalmic artery chemosurgery: Ocular and recurrence-free survival.Comparison between intravenous chemotherapy and intra-arterial chemotherapy for retinoblastoma: a meta-analysis.Current Treatment of Bilateral Retinoblastoma: The Impact of Intraarterial and Intravitreous Chemotherapy.Retinoblastoma
P2860
Q26786290-229BB4DE-0D01-49B5-BD93-C7116F4FEA1DQ26849675-DDE18526-854A-44BE-B4A4-5B3A0FB1FDB5Q28552363-60810DEA-74F6-44FF-AF98-7A34E02AA81AQ33914658-74CFB814-1F0D-4DA0-896E-AF3744280555Q35706804-CE817E66-987B-4093-AFC4-EBD45715E7DCQ36843442-3CA4F036-F124-4E77-AE23-8AA94C4ACDBDQ37038844-C542BF95-3735-4B9E-8FE3-669FAAC6B258Q38199661-D16D012A-C929-4ADB-A2C6-A44463D8C5B5Q38368017-37A8577C-8F09-4B1A-98A3-ACDB9287E4C2Q38709864-1E7C2FA2-2BCE-4B11-9359-2DD2EFDE0ABCQ38950346-F02CE370-0502-4EF8-8025-C4DB43EA918AQ39032221-20A55A66-C2C6-4D17-B6D5-9AC598541596Q39395593-D28DF520-5C4D-4D17-94FA-7A09F9DE0A22Q43040957-6863C6C1-E76F-4368-A21A-7CFB6CA54606Q46118921-0B0D9B36-FEFC-4995-8DC9-51C3850A72FAQ46791376-29A46F7A-2555-4F8A-BAB8-D82C7B8F8F5AQ46878461-665F4142-9D35-4F24-9908-42523941676AQ47647048-C2B50778-AAB3-4D69-A89E-C5C6C865DE14Q49982817-486D3905-618C-4E1C-AA44-1663AF6E5CBAQ51013485-5FA4D6E1-833C-4F6C-9190-B2AE351DDE52Q54944412-09D375EC-6FF2-4A3D-94FF-DE14EBCF21AEQ55021792-446FC4B9-00A6-4B59-9C9D-C71BDFA7F047Q55355864-5D3ED0F6-55B2-4199-9985-52CE0021C90AQ58347703-CC36B081-EB40-4CFB-B5A0-EB320DEE8663
P2860
Long-term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low-dose IMRT salvage.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Long-term outcomes of Group D ...... ion and low-dose IMRT salvage.
@en
type
label
Long-term outcomes of Group D ...... ion and low-dose IMRT salvage.
@en
prefLabel
Long-term outcomes of Group D ...... ion and low-dose IMRT salvage.
@en
P2093
P2860
P356
P1476
Long-term outcomes of Group D ...... tion and low-dose IMRT salvage
@en
P2093
A Linn Murphree
Hashem Almarzouki
Jonathan W Kim
Rima Jubran
Simon R Bababeygy
Thomas C Lee
P2860
P304
P356
10.1002/PBC.24303
P577
2012-09-19T00:00:00Z